EXOSOME-BASED TREATMENT FOR COVID-19-INDUCED ACUTE RESPIRATORY DYSFUNCTION

About Exolitus

Exolitus is a private, pre-revenue biotech leveraging exosome technology for therapeutic and cosmetic applications. Its core focus is on harnessing extracellular vesicles, particularly exosomes, as natural delivery vehicles for bioactive molecules to create next-generation healthcare solutions. The company operates a dual business model, developing its own pipeline for conditions like cancer and cardiovascular disease while offering contract research services and tools to other scientists. With participation in EU-funded projects, Exolitus is positioning itself at the intersection of advanced drug delivery and cutting-edge cosmeceuticals.

Therapeutic Areas